Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 5/20 | 0.45 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496699 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL497016 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL151083 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL437985 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL908021 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL304724 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL303808 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL1239006 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL22608765 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL150843 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| JP-58015592-A | — | — | None | — | — | JP | disclosed |
| WO-2026046961-A1 | ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR PRODUCING RESIST PATTERN, AND METHOD FOR MANUFACTURING DEVICE | MERCK PATENT GMBH (DE) | 2026-03-05 | — | — | WO | disclosed |
| EP-4230775-B1 | TIN ALLOY PLATING SOLUTION | MITSUBISHI MATERIALS CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20250368921-A1 | ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR MANUFACTURING RESIST PATTERN AND METHOD FOR MANUFACTURING DEVICE | MERCK PATENT GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-4649359-A1 | ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR MANUFACTURING RESIST PATTERN AND METHOD FOR MANUFACTURING DEVICE | Merck Patent GmbH (DE) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025228950-A1 | ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR PRODUCING RESIST PATTERN, AND METHOD FOR MANUFACTURING DEVICE | MERCK PATENT GMBH (DE) | 2025-11-06 | — | — | WO | disclosed |
| EP-4643185-A1 | ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR MANUFACTURING RESIST PATTERN AND METHOD FOR MANUFACTURING DEVICE | Merck Patent GmbH (DE) | 2025-11-05 | — | — | EP | disclosed |
| US-4551201-A | Paper sizing composition and method | OLIN CORPORATION (US) | 1985-11-05 | — | — | US | disclosed |
| EP-0098600-A2 | D-mannitol derivatives as starting materials in the synthesis of phospholipids | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-01-18 | — | — | EP | disclosed |
| EP-0072940-A1 | Intermediate products for the production of glycerol derivatives | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1983-03-02 | — | — | EP | disclosed |
| JP-S5815592-A | FLOW-RESISTANT OIL | NIPPON OIL & FATS CO LTD | 1983-01-28 | — | — | JP | disclosed |
| US-4173579-A | DISTILLATION IN AIR TO OXIDIZE IRON PENTACARBONYL | ETHYL CORPORATION (US) | 1979-11-06 | — | — | US | disclosed |
| US-4048118-A | ALKALI METAL SALT OF ORGANIC ACID, AMINE SALT OF PHYTIC ACID | SHOWA DENKO K.K. (JA) | 1977-09-13 | — | — | US | disclosed |
| US-3956252-A | BASIC NITROGEN-CONTAINING SALT OF PHYTIC ACID | SHOWA DENKU K.K. (JA) | 1976-05-11 | — | — | US | disclosed |
| JP-S05815592-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | FAAH 4/4885EPHX2 1062/4885CA2 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.